Detailed Information on Publication Record
2018
Diagnosis of retrocochlear lesions with emphasis on expansion of the cerebellopontine angle
GÁL, Břetislav, Jan ROTTENBERG, Marta PAZOURKOVA, Jiří VANÍČEK, Ermis VOGAZIANOS et. al.Basic information
Original name
Diagnosis of retrocochlear lesions with emphasis on expansion of the cerebellopontine angle
Authors
GÁL, Břetislav (203 Czech Republic, belonging to the institution), Jan ROTTENBERG (203 Czech Republic, guarantor, belonging to the institution), Marta PAZOURKOVA (203 Czech Republic), Jiří VANÍČEK (203 Czech Republic, belonging to the institution) and Ermis VOGAZIANOS (196 Cyprus)
Edition
Biomedical Papers, Olomouc: Palacky University, Olomouc, Palacky University, 2018, 1213-8118
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30206 Otorhinolaryngology
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 1.141
RIV identification code
RIV/00216224:14110/18:00103841
Organization unit
Faculty of Medicine
UT WoS
000445913000003
Keywords (in Czech)
CPA tumours, diagnosis
Keywords in English
CPA tumours; diagnosis
Tags
International impact, Reviewed
Změněno: 2/5/2019 13:56, Soňa Böhmová
Abstract
V originále
The correct diagnosis of CPA tumours is a relatively common issue in both neurological and ENT practice, the omission of which can have serious consequences for the patient. Properly set clinical guidelines and diagnostic protocols are key aspects of good clinical practice. In the case of CPA tumours, two options are available: the first is diagnosis with the help of an ABR as the primary tool for determining the group of patients with a possible tumour; the second is an MRI scan of the posterior cranial fossa. With an appropriately set diagnostic protocol in place, and despite the 40% chance of failure of the ABR to detect tumours less than or equal to 1 cm, similar treatment results can be achieved with much higher cost efficacy in case of primary ABR testing.